DNASE1L3 Inhibits Hepatocellular Carcinoma by Delaying Cell Cycle Progression through CDK2

0
301
Investigators found that DNASE1L3 was significantly downregulated and served as a favorable prognostic factor in HCC.
[Cellular Oncology]
Abstract